These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31101578)
21. Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy. Moschini M; Soria F; Klatte T; Wirth GJ; Özsoy M; Gust K; Briganti A; Roupret M; Susani M; Haitel A; Shariat SF Clin Genitourin Cancer; 2017 Apr; 15(2):e267-e273. PubMed ID: 27530435 [TBL] [Abstract][Full Text] [Related]
22. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy. Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820 [TBL] [Abstract][Full Text] [Related]
23. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis. Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102 [TBL] [Abstract][Full Text] [Related]
24. Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model. Al-Alao O; Mueller-Leonhard C; Kim SP; Amin A; Tucci C; Kott O; Mega A; Golijanin D; Gershman B Urol Oncol; 2020 Mar; 38(3):76.e19-76.e28. PubMed ID: 31590968 [TBL] [Abstract][Full Text] [Related]
25. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. Soave A; John LM; Dahlem R; Minner S; Engel O; Schmidt S; Kluth LA; Fisch M; Rink M Urology; 2015 Jul; 86(1):92-8. PubMed ID: 26051839 [TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy. Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209 [TBL] [Abstract][Full Text] [Related]
27. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy. Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857 [TBL] [Abstract][Full Text] [Related]
28. The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration. Afferi L; Zamboni S; Karnes RJ; Roghmann F; Sargos P; Montorsi F; Briganti A; Gallina A; Mattei A; Schulz GB; Hendricksen K; Voskuilen CS; Rink M; Poyet C; De Cobelli O; di Trapani E; Simeone C; Soligo M; Simone G; Tuderti G; Alvarez-Maestro M; Martínez-Piñeiro L; Aziz A; Shariat SF; Abufaraj M; Xylinas E; Moschini M; World J Urol; 2021 Feb; 39(2):443-451. PubMed ID: 32356226 [TBL] [Abstract][Full Text] [Related]
29. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience. Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522 [TBL] [Abstract][Full Text] [Related]
30. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065 [TBL] [Abstract][Full Text] [Related]
31. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045 [TBL] [Abstract][Full Text] [Related]
32. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Soloway MS; Lopez AE; Patel J; Lu Y Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219 [TBL] [Abstract][Full Text] [Related]
34. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A; BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486 [TBL] [Abstract][Full Text] [Related]
35. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer. Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162 [TBL] [Abstract][Full Text] [Related]
36. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211 [TBL] [Abstract][Full Text] [Related]
37. Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy. von Landenberg N; Speed JM; Cole AP; Seisen T; Lipsitz SR; Gild P; Menon M; Kibel AS; Roghmann F; Noldus J; Sun M; Trinh QD Urol Oncol; 2018 Feb; 36(2):78.e13-78.e19. PubMed ID: 29169845 [TBL] [Abstract][Full Text] [Related]
38. Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study. Rosiello G; Pecoraro A; Palumbo C; Knipper S; Luzzago S; Deuker M; Tian Z; Gandaglia G; Fossati N; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI World J Urol; 2021 Mar; 39(3):813-822. PubMed ID: 32424515 [TBL] [Abstract][Full Text] [Related]
39. The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy. Gronostaj K; Czech AK; Fronczek J; Drobniak A; Okon K; Chlosta PL; Szczeklik W Clin Genitourin Cancer; 2019 Dec; 17(6):e1203-e1211. PubMed ID: 31588010 [TBL] [Abstract][Full Text] [Related]
40. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]